-
Merck Announces First-Quarter 2020 Financial Results
Post on 4/28/20
-
Pfizer Reports First-Quarter 2020 Results
Post on 4/28/20
-
Arvinas Reports First Quarter 2020 Financial Results and Provides a Corporate Update
Post on 4/28/20
-
Biohaven Enters Into Agreement With Genpharm
Post on 4/27/20
-
AMC Health Expands Partnership with Geisinger Health
Post on 4/27/20
-
States Where Social Distancing Is Most Difficult – WalletHub Study
Post on 4/27/20
-
70% of Investors Believe a COVID-19 Recession Will Be Worse Than 2008 -- But Here's the Silver Lining
Post on 4/27/20
-
While Big Pharma Tanked, Gilead Sciences and Regeneron Soared
Post on 4/27/20
-
Teladoc Earnings Preview: What to Watch
Post on 4/27/20
-
Cyclacel Closes $20M Public Offering
Post on 4/26/20
-
Caladrius Biosciences Announces $5M Registered Direct Offering
Post on 4/26/20
-
AzurRx BioPharma Issues Letter to Shareholders
Post on 4/26/20
-
Actinium Pharmaceuticals Closes $31.6M Public Offering
Post on 4/26/20
-
Johnson & Johnson Taps Emergent BioSolutions to Help Manufacture Its COVID-19 Vaccine
Post on 4/24/20
-
Pfizer Declares $0.38 Dividend
Post on 4/24/20
-
Pfizer Targets Summer For COVID-19 Vaccine Human Trials; Potential Treatment Also In The Works
Post on 4/24/20
-
Better Buy: Amgen vs. Johnson & Johnson
Post on 4/24/20
-
Here's Why Immunomedics Shares Are Skyrocketing Today
Post on 4/24/20
-
Click Therapeutics Launches New Brand Identity and Redesigned Website
Post on 4/23/20
-
Immunic Prices $15 Million Financing
Post on 4/23/20
-
Chardan Healthcare Acquisition 2 Corp. Prices $85M IPO
Post on 4/23/20
-
Celsion Receives $2.5 Million Funding
Post on 4/23/20
-
Why You're Smart to Buy Bristol Myers Squibb
Post on 4/23/20
-
Johnson & Johnson: The Defensive Stock To Own Through COVID-19
Post on 4/23/20
-
Will Johnson & Johnson's Coronavirus Vaccine Dominate the Market?
Post on 4/23/20
New York
